Department of Surgery, Clinical Hospital, University of Chile
Santiago, Santiago Metropolitan, Chile
NCT Number: NCT00935779
Peritoneal metastases appear in a great proportion of patients affected by gastric carcinoma. Involved mechanisms are poorly understood though experimentally it has been demonstrated that neoplastic cells exfoliated from primary tumor can only implant and proliferate in areas of damaged peritoneum. Objectives: to study ultra-structure of peritoneal surface by electronic microscopy in control subjects and in patients with early or locally advanced gastric cancer looking for spontaneous changes in peritoneal surface not related with surgical injury.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Santiago, Santiago Metropolitan, Chile
18 out of 32 cases were eligible for analysis. Four patients operated on for benign diseases served as control and 14 patients with operable local gastric adenocarcinoma (4 mucosa/submucosa/muscular y 10 serosa lesions) were studied. At the beginning of surgery, a 2 x 2 cm. sample from macroscopically normal visceral peritoneum at mesenterium root was carefully obtained, washed with saline and fixed in glutaraldehyde solution. Besides a sample of peritoneal washing fluid was studied to exclude patients with free cancer cells. Peritoneal tissue was fixed during 24 hours and then all samples were evaluated by electronic microscope.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University of Chile
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03013010
Adenocarcinoma, Carcinoma
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT06563063
Digestive System Diseases, Digestive System Neoplasms
Seoul, South Korea
View Trial DetailsNCT05714878
Digestive System Diseases, Digestive System Neoplasms
Beijing, China
View Trial DetailsNCT03549494
Digestive System Disease, Digestive System Diseases
Havana, La Habana, Cuba
View Trial Details